GSK3039294
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3039294, covering 2019-09-23 to 2019-09-23. Get the full timeline:
Most recent: Clinical Trial Update: A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis [Phase 1]